Traws Pharma Enters Material Definitive Agreement
Ticker: TRAW · Form: 8-K · Filed: Feb 19, 2025 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 8-K |
| Filed Date | Feb 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
Traws Pharma just signed a big deal, filing an 8-K today.
AI Summary
Traws Pharma, Inc. entered into a material definitive agreement on February 18, 2025. The filing also includes financial statements and exhibits related to this agreement. The company is incorporated in Delaware and its principal business address is in Newtown, PA.
Why It Matters
This filing indicates a significant new contract or partnership for Traws Pharma, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the specifics of which are not detailed in this initial filing.
Key Players & Entities
- Traws Pharma, Inc. (company) — Registrant
- February 18, 2025 (date) — Date of earliest event reported
- Newtown, PA (location) — Business Address
- Onconova Therapeutics, Inc. (company) — Former Company Name
FAQ
What is the nature of the material definitive agreement entered into by Traws Pharma, Inc.?
The filing states that Traws Pharma, Inc. entered into a material definitive agreement on February 18, 2025, but the specific details of the agreement are not provided in this initial 8-K filing.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 18, 2025.
What is Traws Pharma, Inc.'s state of incorporation?
Traws Pharma, Inc. is incorporated in Delaware.
What is the business address of Traws Pharma, Inc.?
The business address of Traws Pharma, Inc. is 12 Penns Trail, Newtown, PA 18940.
Has Traws Pharma, Inc. had previous names?
Yes, Traws Pharma, Inc. was formerly known as Onconova Therapeutics, Inc., with name changes recorded on May 26, 2009, and December 26, 2000.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 19, 2025 regarding Traws Pharma, Inc. (TRAW).